Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00844181 · ClinicalTrials.gov registry record

Racial Differences in Orthostatic Tolerance

A clinical trial, sponsored by Yale University.

Completed
Registry status
18
Enrollment target

NCT00844181 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00844181 has completed, sponsored by Yale University.

COMPLETED
Registry status
18 participants
Enrollment target

Study Summary

Our central hypothesis is that baroreflex sensitivity is attenuated in black women compared to white women, and that this dysregulation will be apparent during orthostatic challenges. We expect that the cumulative stress index (CSI), a measure of maximal orthostatic tolerance, is higher in Black women (BW) compared to White women (WW).

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2007-10
Est. Completion 2009-01

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT00844181

The ClinicalTrials.gov registry entry for NCT00844181 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00844181 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00844181 about?

NCT00844181 is a clinical study titled "Racial Differences in Orthostatic Tolerance". Our central hypothesis is that baroreflex sensitivity is attenuated in black women compared to white women, and that this dysregulation will be apparent during orthostatic challenges. We expect that the cumulative stress index (CSI), a measure of maximal orthostatic tolerance, is higher in Black wom...

What is the current status of trial NCT00844181?

This trial is currently completed. The enrollment target is 18 participants. The study started on 2007-10. Estimated completion is 2009-01.

Who is sponsoring clinical trial NCT00844181?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.